Politics Trump budget to include billions to combat opioid epidemic

12:56  12 february  2018
12:56  12 february  2018 Source:   The Hill

Despite opioid 'emergency,' drug office dwindles under Trump

  Despite opioid 'emergency,' drug office dwindles under Trump One member, a recent graduate of St. John's University, left after questions about his lack of experience.A group that included nine political appointees a year ago has been cut to a third of that size, according to a Political report that said the White House's drug initiatives “look more like a war on his drug policy office.

Meanwhile, Trump has provided no new funding to combat the epidemic . According to a report from the Congressional Budget Office, the repeal will increase the number of uninsured Americans by 13 million over Related. Republicans Just Tried to Claim that Medicaid Caused the Opioid Epidemic .

Trump ’s budget cuts could make the core opioid problem worse. The fundamental problem in the opioid crisis is that America needs to put a lot more resources toward drug addiction And Congress in 2016, with Obama’s approval, allocated billion over two years to combat the opioid epidemic .

  Trump budget to include billions to combat opioid epidemic © Provided by The Hill

President Trump's budget will propose billions of dollars to combat the opioid epidemic plaguing the country, months after the administration designated the crisis a national public health emergency.

The White House's fiscal 2019 budget set to be released Monday will include nearly $17 billion for the opioid epidemic that's killing more Americans per year than car accidents, according to an outline from the Office of Management and Budget (OMB).

The Department of Health and Human Services will specifically receive a large chunk of those dollars to expand prevention, treatment, recovery and mental health services - $3 billion for 2018 and $10 billion for 2019, according to the outline.

Alabama sues OxyContin maker Purdue Pharma over opioid epidemic

  Alabama sues OxyContin maker Purdue Pharma over opioid epidemic <p>Alabama on Tuesday became the latest state to file a lawsuit accusing OxyContin maker Purdue Pharma LP of fueling the opioid epidemic by deceptively marketing prescription painkillers to generate billions of dollars in sales.</p>Alabama Attorney General Steve Marshall alleged in a lawsuit filed in a federal court that Purdue misrepresented the risks and benefits of opioids, enabling the widespread prescribing of the drugs for chronic pain conditions.

While experts talk about needing as much as tens of billions of dollars for the crisis over the next few years, that’s actually not much in federal budget terms — a Trump has been all talk, no action. “The administration has done very little to combat the opioid epidemic to date,” Gary Mendell, founder

WASHINGTON – U.S. Senators Jeanne Shaheen (D-NH) and Maggie Hassan (D-NH) yesterday announced a proposal to include billion in additional funding to combat the opioid crisis in the budget In late October, Trump declared the opioid epidemic a national public health emergency.

The two-year budget deal Congress passed includes $6 billion over the next two years to help with mental health and opioid addiction. OMB's outline says the president's budget will account for the recent spending caps deal.

In mid-October, Trump declared the epidemic a national public health emergency, a move which the administration extended another 90 days last month.

The money didn't free up millions of more dollars nor did it include a request to Congress for more funding, which has frustrated addiction advocates. They've argued more funding is needed to make the move effective in combating the rising rate of opioid overdose deaths, which increased nearly 28 percent from 2015 to 2016.

Every year, the president releases its budget, but Congress has the power of the purse, and often ignores or changes the White House's asks. Yet, the document serves as a window into the administration's priorities.

Opioid makers gave $10 million to drug advocacy groups .
<p>Companies selling some of the most lucrative prescription painkillers funneled millions of dollars to advocacy groups that in turn promoted the medications' use, according to a report released this past week by a U.S. senator.</p>The investigation by Missouri's Sen. Claire McCaskill shed light Monday on the opioid industry's ability to shape public opinion and raises questions about its role in an overdose epidemic that has claimed hundreds of thousands of American lives. Representatives of some of the drugmakers named in the report said they did not set conditions on how the money was to be spent or force the groups to advocate for their painkillers.

—   Share news in the SOC. Networks

Topical videos:

This is interesting!